![]() |
市場調查報告書
商品編碼
2082063
醫療保健領域區塊鏈技術市場:按組件、資料儲存架構、應用、最終用戶、部署模型和組織規模分類-2026-2032年全球市場預測Blockchain Technology in Healthcare Market by Component, Data Storage Architecture, Application, End User, Deployment Mode, Organization Size - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,醫療保健領域的區塊鏈技術市場將成長至 301.7 億美元,複合年成長率為 14.50%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 116.9億美元 |
| 預計年份:2026年 | 132.9億美元 |
| 預測年份 2032 | 301.7億美元 |
| 複合年成長率 (%) | 14.50% |
區塊鏈技術在醫療保健領域的應用正從概念驗證(PoC)階段邁向目標部署階段,例如資料交換、藥品溯源、臨床研究、保險理賠管理、醫療服務提供者認證和病患知情同意管理等領域。這項技術的核心價值並非取代電子健康記錄,而是圍繞分散的醫療保健工作流程來建構一個信任層,提供防篡改、時間戳記和存取控制等功能。
需求受可衡量的壓力影響。醫療保健產業仍然是資料外洩成本最高的產業之一,IBM 發布的《2024 年資料外洩成本報告》連續第 14 年將其列為成本最高的產業。此外,世界衛生組織的報告指出,中低收入國家十分之一的醫療產品不合格或仿冒品。這些現實情況促使人們對基於區塊鏈的醫療保健資料安全、藥品供應鏈檢驗、數位身分和可互通的審計追蹤等技術越來越感興趣。
醫療保健區塊鏈的發展趨勢正從廣泛的企業級區塊鏈應用轉向符合標準的實用用例。許可型區塊鏈網路越來越受歡迎,因為它們允許受監管的機構定義管治、進入許可權、資料儲存位置和可審計性,同時避免直接將受保護的醫療資訊上鍊所帶來的隱私風險。
人工智慧 (AI) 透過提升臨床和營運數據的數量、保密性和價值,增強了區塊鏈在醫療保健領域的戰略重要性。用於診斷、人群健康管理、醫學影像、藥物研發和收入週期管理的 AI 模型需要可信的資料處理歷程、知情同意證明和模型管治,以減少偏差、保護隱私並協助監管審查。
北美憑藉其先進的數位醫療基礎設施、高昂的醫療費用支出、對網路安全的巨大壓力以及注重互通性和藥品溯源的監管,在醫療保健領域的區塊鏈商業化進程中處於領先地位。美國以HIPAA、DSCSA和ONC等互通性規則以及大規模的支付方、醫療服務提供者和技術生態系統為特徵,而加拿大則更側重於省級醫療保健資料管治和安全身分框架。
在主要經濟和政策集團中,七國集團(G7)是關鍵的需求中心。這是因為其成員國擁有成熟的醫療保健體系、嚴格的隱私法、先進的醫藥創新以及積極主動的人工智慧管治。歐盟透過《一般資料保護規範》(GDPR)、歐洲健康資料空間以及促進檢驗和基於同意的資料交換的跨境數位身分舉措,擁有特別強大的影響力。
美國仍然是醫療保健領域區塊鏈技術商業化程度最高的市場,這主要得益於《藥品供應鏈安全法案》(DSCSA) 的可追溯性要求、大規模保險公司之間錯綜複雜的關係、HIPAA 合規性需求、ONC互通性規則以及對數位醫療領域的大力投資。加拿大正透過安全的資料共用和省級互通性項目取得進展,而墨西哥和巴西則在藥品真偽驗證、保險工作流程和商業性現代化方面看到了機會。
產業領導者應優先考慮區塊鏈技術能夠解決溯源、審計或多方協調等問題的應用情境。高價值的切入點包括藥品溯源、臨床試驗知情同意取得、醫療服務提供者認證、保險理賠匹配、醫療設備生命週期追蹤以及病患主導的資料存取。
本執行摘要採用以二手資料研究主導的調查方法撰寫,符合市場情報最佳實踐。分析整合了來自權威公共衛生機構、法規結構、行業標準化組織、網路安全研究、藥品可追溯性要求以及數位健康政策舉措的資訊。
在醫療保健領域,區塊鏈技術正逐漸成為實用的信任基礎設施,尤其是在日益數位化、人工智慧驅動和監管化的領域。其最具前景的應用情境是:醫療保健相關人員需要在不放棄對敏感資料控制權的前提下共用檢驗。
The Blockchain Technology in Healthcare Market is projected to grow by USD 30.17 billion at a CAGR of 14.50% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 11.69 billion |
| Estimated Year [2026] | USD 13.29 billion |
| Forecast Year [2032] | USD 30.17 billion |
| CAGR (%) | 14.50% |
Blockchain technology in healthcare is moving from proof-of-concept experimentation to targeted deployment across data exchange, drug traceability, clinical research, claims administration, provider credentialing, and patient consent management. The technology's core value is not replacing electronic health records, but creating tamper-evident, time-stamped, and permissioned trust layers around fragmented healthcare workflows.
Demand is being shaped by measurable pressures: healthcare remains one of the most expensive sectors for data breaches, IBM's 2024 Cost of a Data Breach Report identified healthcare as the highest-cost industry for the 14th consecutive year, and the WHO has reported that 1 in 10 medical products in low- and middle-income countries is substandard or falsified. These realities are increasing interest in blockchain-based healthcare data security, pharmaceutical supply chain verification, digital identity, and interoperable audit trails.
The healthcare blockchain landscape is shifting from broad enterprise blockchain claims toward practical, standards-aligned use cases. Permissioned blockchain networks are gaining preference because they allow regulated organizations to define governance, access rights, data residency, and auditability while avoiding the privacy risks of placing protected health information directly on-chain.
Regulatory and industry mandates are accelerating adoption. The U.S. Drug Supply Chain Security Act, the EU Falsified Medicines Directive, unique device identification requirements, HL7 FHIR adoption, and privacy frameworks such as HIPAA and GDPR are strengthening the need for verifiable data provenance. As a result, healthcare organizations are focusing on off-chain data storage with on-chain hashes, smart contracts for workflow automation, and verifiable credentials for trusted exchange.
Artificial intelligence is increasing the strategic relevance of blockchain in healthcare by expanding the volume, sensitivity, and value of clinical and operational data. AI models used in diagnostics, population health, medical imaging, drug discovery, and revenue cycle management require trusted data lineage, consent evidence, and model governance to reduce bias, protect privacy, and support regulatory review.
Blockchain can strengthen AI-enabled healthcare by recording dataset provenance, consent status, access events, and model audit trails without exposing raw patient data. It also complements privacy-preserving technologies such as federated learning, secure multiparty computation, and zero-knowledge proofs. The cumulative impact is a more accountable healthcare AI ecosystem in which data can be shared, validated, and monetized with stronger safeguards.
North America leads in healthcare blockchain commercialization due to advanced digital health infrastructure, high healthcare spending, strong cybersecurity pressure, and regulatory focus on interoperability and drug traceability. The United States is shaped by HIPAA, DSCSA, ONC interoperability rules, and a large payer-provider-technology ecosystem, while Canada emphasizes provincial health data governance and secure identity frameworks.
Europe is advancing through GDPR-driven privacy requirements, the European Health Data Space, and established medicine verification systems under the EU Falsified Medicines Directive. Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN economies digitize health records, telehealth, insurance, and pharmaceutical logistics. Latin America, including Brazil and Mexico, is adopting blockchain selectively for medicine authentication, claims transparency, and public health modernization, while the Middle East is supported by national digital health strategies, smart hospital investments, and secure health data platforms across GCC countries. Africa shows targeted potential in anti-counterfeit medicines, vaccination records, donor-funded health programs, and identity-linked access to care, particularly where fragmented infrastructure and trust gaps remain pronounced.
Among major economic and policy groups, the G7 is a leading demand center because its members combine mature healthcare systems, strict privacy laws, high pharmaceutical innovation, and active AI governance. The European Union is especially influential through GDPR, the European Health Data Space, and cross-border digital identity initiatives that favor verifiable and consent-driven data exchange.
BRICS markets are important for scale, as China and India are investing heavily in digital health infrastructure and pharmaceutical traceability, while Brazil, Russia, and South Africa face incentives to strengthen public health data integrity and supply chain assurance. ASEAN presents a fast-growing opportunity as member states expand universal health coverage, e-pharmacy, and regional logistics. GCC countries are investing in smart hospitals, national health data platforms, and secure digital identity, while NATO members' cybersecurity priorities reinforce demand for resilient healthcare infrastructure, protected medical supply chains, and trusted data exchange across defense-linked and civilian health systems.
The United States remains the most commercially mature market for blockchain technology in healthcare due to DSCSA traceability requirements, large-scale payer complexity, HIPAA compliance needs, ONC interoperability rules, and strong digital health investment. Canada is advancing through secure data-sharing and provincial interoperability programs, while Mexico and Brazil show opportunity in pharmaceutical authentication, insurance workflows, and public health modernization.
In Europe, the United Kingdom, Germany, France, Italy, and Spain are influenced by privacy-first data exchange, medicine verification, electronic health record modernization, and broader digital health programs aligned with GDPR principles. Russia's market is shaped by domestic digital infrastructure, data localization priorities, and pharmaceutical control systems. In Asia-Pacific, China and India offer scale in health data platforms, e-pharmacy, public insurance digitization, and anti-counterfeit measures; Japan, South Korea, and Australia emphasize secure interoperability, medical research, advanced hospital systems, and high-trust digital identity in mature healthcare environments.
Industry leaders should prioritize blockchain use cases where the technology solves a provenance, audit, or multi-party coordination problem. High-value starting points include drug traceability, clinical trial consent, provider credentialing, claims reconciliation, medical device lifecycle tracking, and patient-mediated data access.
Organizations should avoid storing protected health information directly on-chain and instead use privacy-preserving architecture that combines off-chain repositories, tokenized permissions, cryptographic hashes, and role-based access. Successful deployment requires governance before technology: define network participants, liability, data standards, smart contract controls, cybersecurity protocols, and compliance obligations. Leaders should align with HL7 FHIR, DSCSA, GDPR, HIPAA, and local health data rules from the outset.
This executive summary is developed using a secondary research-led methodology aligned with market intelligence best practices. The analysis synthesizes information from recognized public health agencies, regulatory frameworks, industry standards bodies, cybersecurity studies, pharmaceutical traceability requirements, and digital health policy initiatives.
Key reference areas include WHO guidance on falsified medicines, IBM healthcare breach cost reporting, U.S. DSCSA implementation, EU Falsified Medicines Directive requirements, GDPR, HIPAA, HL7 FHIR interoperability standards, W3C decentralized identity and national digital health strategies. Insights are validated through triangulation across regulatory evidence, technology adoption trends, healthcare workflow needs, and observed enterprise deployment patterns.
Blockchain technology in healthcare is becoming a practical trust infrastructure for an increasingly digital, AI-enabled, and regulated sector. Its strongest applications are emerging where healthcare stakeholders need shared verification without surrendering control of sensitive data.
The next phase of blockchain adoption in healthcare will favor permissioned networks, privacy-preserving design, compliance-ready interoperability, and measurable operational outcomes. Organizations that connect blockchain with AI governance, pharmaceutical integrity, patient consent, and secure health data exchange will be best positioned to reduce risk, improve transparency, and build resilient healthcare ecosystems.